Under the Lens: Taking a Close Look at the NIH and FDA Declarations on Animal-Based Research

How animal testing became a MAHA political wedge issue While cancer scientists say NIH, FDA moves are premature, animal rights advocates say changes aren’t drastic enough

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the…

Under the lens: Taking a close look at the NIH and FDA declarations on animal-based research

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL).  This content is for Group 1 - Individual Seat, Individual Subscription - Ann…